NewAmsterdam Pharma Company NV banner
N

NewAmsterdam Pharma Company NV
F:KH6

Watchlist Manager
NewAmsterdam Pharma Company NV
F:KH6
Watchlist
Price: 26.6 EUR 4.19% Market Closed
Market Cap: €127.3B

Bankruptcy Probability

NewAmsterdam Pharma Company NV's probability of bankruptcy is Hidden . The solvency score is Hidden .

We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.

Probability of Bankruptcy
LOCKED
Unlock

Financial Position

Cash & Short-Term Investments
+
Jun 30, 2023 383.5m
Dec 31, 2022 438.5m
Sep 30, 2022 375.6k
Jun 30, 2022 615.4k
Long-Term Investments
+
Jun 30, 2023 0
Dec 31, 2022 0
Sep 30, 2022 138.8m
Jun 30, 2022 138.1m
Debt
+
Jun 30, 2023 23k
Dec 31, 2022 56k
Sep 30, 2022 0
Jun 30, 2022 0

Solvency Ratios

Solvency Ratios Comparison
NewAmsterdam Pharma Company NV Competitors

Country Company Market Cap D/E D/A Interest
Coverage
Altman
Z-Score
Quick
Ratio
Current
Ratio
Cash
Ratio
NL
NewAmsterdam Pharma Company NV
NASDAQ:NAMS
3.5B USD
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
JP
Takara Bio Inc
TSE:4974
120.4T JPY
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
US
Abbvie Inc
NYSE:ABBV
393.3B USD
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
187.8B USD
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
158B USD
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
115.2B USD
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
65B USD
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
NL
argenx SE
XBRU:ARGX
46.8B EUR
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
US
Seagen Inc
F:SGT
39.3B EUR
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
No Stocks Found
Is NewAmsterdam Pharma Company NV at risk of bankruptcy?

NewAmsterdam Pharma Company NV's probability of bankruptcy is Hidden .

The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.

How much debt does NewAmsterdam Pharma Company NV have?

As of the latest report, NewAmsterdam Pharma Company NV has total debt of 23k EUR. This includes both short-term (0 EUR) and long-term (23k EUR) debt.

You can find a full breakdown on its Balance Sheet.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett